Related Experiment Videos
In vitro studies with cefaclor, a new oral cephalosporin
Abstract:
In vitro studies were performed to evaluate the activity of cefaclor in comparison with cephalexin against 180 clinical isolates. Broth dilution susceptibility tests showed cefaclor to be 4- to 16-fold more active than cephalexin against Streptococcus pneumoniae, Haemophilus influenzae, and cephalothin-susceptible Enterobacteriaceae. Neither drug was highly active against cephalothin-resistant Enterobacteriaceae or methicillin-resistant Staphylococcus aureus. Cefaclor zones with 30-mug disks were generally larger than cephalexin zones, 4 mm larger than cephalothin zones against Enterobacteriaceae, and 6 mm smaller than cephalothin zones against S. aureus. Quantitative kill curves indicated that killing by both cefaclor and cephalexin was slow and often incomplete over a 24-h period. Cefaclor-induced filamentation of gram-negative bacilli was not as extensive as that produced by cephalexin, and some spherule formation did occur. However, cefaclor was significantly more unstable in solution than cephalexin, with a half-life of less than 6 h at 37 degrees C. Thus, results obtained in tests after prolonged incubation may not provide an accurate measure of cefaclor's activity.
Insights
Cefaclor demonstrated greater in vitro activity than cephalexin against certain bacteria, but its instability in solution may affect test results. Further research is needed to understand cefaclor
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Cefaclor and cephalexin are cephalosporin antibiotics used to treat bacterial infections.
- Understanding their comparative efficacy and limitations is crucial for effective antimicrobial therapy.
Purpose of the Study:
- To compare the in vitro activity of cefaclor and cephalexin against 180 clinical bacterial isolates.
- To assess the impact of drug stability on susceptibility testing results.
Main Methods:
- Broth dilution susceptibility testing.
- Disk diffusion assays.
- Quantitative kill curves.
- Assessment of drug stability in solution at 37°C.
Main Results:
- Cefaclor showed 4- to 16-fold greater activity than cephalexin against Streptococcus pneumoniae, Haemophilus influenzae, and cephalothin-susceptible Enterobacteriaceae.
- Both antibiotics were less effective against cephalothin-resistant Enterobacteriaceae and methicillin-resistant Staphylococcus aureus.
- Cefaclor exhibited significantly lower stability in solution (half-life < 6 hours at 37°C) compared to cephalexin.
Conclusions:
- Cefaclor possesses superior in vitro potency against specific pathogens compared to cephalexin.
- The instability of cefaclor in solution necessitates careful interpretation of susceptibility data, especially after prolonged incubation.
- Further investigation into cefaclor's clinical efficacy considering its stability profile is warranted.